BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12227473)

  • 1. Cytometric evaluation of peripheral blood lymphocytes in dogs with lymphoma during chemotherapy.
    Winnicka A; Jagielski D; Hoffmann-Jagielska M; Lechowski R
    J Vet Med A Physiol Pathol Clin Med; 2002 Aug; 49(6):303-6. PubMed ID: 12227473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine lymphoma.
    Madewell BR
    Vet Clin North Am Small Anim Pract; 1985 Jul; 15(4):709-22. PubMed ID: 2412330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma.
    Culmsee K; Simon D; Mischke R; Nolte I
    J Vet Med A Physiol Pathol Clin Med; 2001 May; 48(4):199-206. PubMed ID: 11413979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric immunophenotype of canine lymph node aspirates.
    Gibson D; Aubert I; Woods JP; Abrams-Ogg A; Kruth S; Wood RD; Bienzle D
    J Vet Intern Med; 2004; 18(5):710-7. PubMed ID: 15515589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
    Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
    J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition of lymphocyte subpopulations in normal canine lymph nodes.
    Rütgen BC; König R; Hammer SE; Groiss S; Saalmüller A; Schwendenwein I
    Vet Clin Pathol; 2015 Mar; 44(1):58-69. PubMed ID: 25512102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunophenotype of peripheral blood lymphocytes in clinically healthy dogs and dogs with lymphoma in remission.
    Gauthier MJ; Aubert I; Abrams-Ogg A; Woods JP; Bienzle D
    J Vet Intern Med; 2005; 19(2):193-9. PubMed ID: 15822563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
    Jeglum KA; Winters WD; Young KM
    Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
    Wang SL; Lee JJ; Liao AT
    Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of peripheral blood lymphocyte subsets in canine lymphoma.
    Miniscalco B; Guglielmino R; Morello E; Tarducci A; Geuna M
    Vet Res Commun; 2003 Sep; 27 Suppl 1():407-9. PubMed ID: 14535441
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
    Hosoya K; Kisseberth WC; Lord LK; Alvarez FJ; Lara-Garcia A; Kosarek CE; London CA; Couto CG
    J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
    J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
    Jeglum KA; Young KM; Barnsley K; Whereat A
    Cancer; 1988 May; 61(10):2042-50. PubMed ID: 3359402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is your diagnosis? Ocular lymphoma.
    Cave T; Billson M
    J Small Anim Pract; 2003 Dec; 44(12):523, 553-4. PubMed ID: 14692547
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin.
    Tater G; Eberle N; Hungerbuehler S; Joetzke A; Nolte I; Wess G; Betz D
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):261-6. PubMed ID: 22911257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide and prednisolone for chemotherapy naïve B cell multicentric lymphoma in dogs: 32 cases (2017-2021).
    Todd J; Thomas P; Nguyen S
    J Small Anim Pract; 2022 Jan; 63(1):52-55. PubMed ID: 34647324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibility of the comparative evaluation of chemotherapy effectiveness in hemoblastoses in man and dogs].
    Kliuchanskaia NV; Iliukhin AV
    Vestn Akad Med Nauk SSSR; 1986; (5):68-70. PubMed ID: 3755270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.